Pharmaids Pharmaceuticals Quarterly Results for Trading Insights
In Mar 2026, Pharmaids Pharmaceuticals (PHARMAID) reported revenue ₹7 Cr and net profit ₹-1 Cr — revenue +40.0% YoY. Browse PHARMAID complete financial statements for revenue, profit, balance sheet and cash flow data.
PHARMAID Quarterly Results — Revenue, Profit & EPS Highlights
Pharmaids Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Pharmaids Pharmaceuticals share price screener.
- Revenue of ₹7 Cr in Mar 2026 (-12.5% vs Jun 2026, +40.0% vs Mar 2025)
- Net Profit of ₹-1 Cr in Mar 2026 (-150.0% vs Jun 2026, +80.0% vs Mar 2025)
- Operating Margin of -6.0% in Mar 2026 (+12.0pp vs Jun 2026)
- Earnings Per Share of ₹-0.51 in Mar 2026 (-181.0% vs Jun 2026)
Pharmaids Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS
PHARMAID quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 7 | 8 | 12 | 5 | 7 | -12.5% | 40.0% |
| Net Profit (₹ Cr) | -1 | 2 | -3 | -5 | -5 | - | - |
| EBITDA (₹ Cr) | 0 | 4 | -2 | -4 | -5 | - | - |
| EPS (₹) | -0.51 | 0.63 | -0.70 | -1.11 | -1.39 | - | - |
| Operating Margin (%) | -6.0% | -18.0% | -62.0% | -82.0% | -81.0% | - | - |
PHARMAID Share Price Trend — 1-Year Movement Across Quarterly Results
Pharmaids Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore PHARMAID stock price history to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
PHARMAID vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Pharmaids Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹463,071.60 Cr | 1902.4 | 15,018 | 2,710 | -5.6% | - | 18.0% | 168.4 |
|
Divis Laboratories
Mar 2026 |
₹225,157.18 Cr | 8597.0 | 2,986 | 751 | -5.0% | - | 25.2% | 303.7 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4896.5 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 425.4 |
|
Cipla
Mar 2026 |
₹114,875.60 Cr | 1432.2 | 6,612 | 543 | -9.3% | - | 8.2% | 208.5 |
|
Zydus Life Science
Mar 2026 |
₹113,855.38 Cr | 1120.0 | 7,569 | 1,341 | -4.3% | - | 17.7% | 88.5 |
All amounts in ₹ Crores